Hepatitis C treatment and liver cancer recurrence: cause for concern?

Lancet Gastroenterol Hepatol. 2017 Feb;2(2):78-80. doi: 10.1016/S2468-1253(16)30204-7. Epub 2017 Jan 12.

Authors

Jose D Debes¹, Harry L A Janssen², Andre Boonstra³

Affiliations

¹ Department of Medicine, University of Minnesota, Minneapolis, MN, USA. Electronic address: [email protected].
² Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, ON, Canada.
³ Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.

PMID: 28403989
DOI: 10.1016/S2468-1253(16)30204-7

No abstract available

MeSH terms

Antiviral Agents / adverse effects*
Antiviral Agents / therapeutic use
Carcinoma, Hepatocellular / immunology*
Hepatitis C, Chronic / drug therapy*
Hepatitis C, Chronic / immunology*
Humans
Immunomodulation
Liver Neoplasms / immunology*
Neoplasm Recurrence, Local / immunology*

Substances

Antiviral Agents